UBS Group’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.72M | Buy |
385,856
+131,184
| +52% | +$1.92M | ﹤0.01% | 3932 |
|
|
2025
Q4 | $4.06M | Buy |
254,672
+55,924
| +28% | +$793K | ﹤0.01% | 4238 |
|
|
2025
Q3 | $2.2M | Sell |
198,748
-126,881
| -39% | -$1.39M | ﹤0.01% | 4853 |
|
|
2025
Q2 | $2.76M | Buy |
325,629
+68,490
| +27% | +$549K | ﹤0.01% | 4480 |
|
|
2025
Q1 | $2.07M | Buy |
257,139
+43,866
| +21% | +$355K | ﹤0.01% | 4675 |
|
|
2024
Q4 | $1.92M | Buy |
213,273
+62,574
| +42% | +$511K | ﹤0.01% | 4760 |
|
|
2024
Q3 | $1.1M | Buy |
150,699
+13,525
| +10% | +$83.9K | ﹤0.01% | 4569 |
|
|
2024
Q2 | $783K | Sell |
137,174
-63,608
| -32% | -$335K | ﹤0.01% | 4644 |
|
|
2024
Q1 | $1.01M | Sell |
200,782
-52,706
| -21% | -$358K | ﹤0.01% | 4597 |
|
|
2023
Q4 | $2.28M | Buy |
253,488
+61,306
| +32% | +$505K | ﹤0.01% | 3668 |
|
|
2023
Q3 | $1.49M | Sell |
192,182
-50,188
| -21% | -$491K | ﹤0.01% | 3736 |
|
|
2023
Q2 | $2.35M | Buy |
242,370
+110,901
| +84% | +$1.15M | ﹤0.01% | 3374 |
|
|
2023
Q1 | $1.44M | Buy |
131,469
+84,912
| +182% | +$748K | ﹤0.01% | 3762 |
|
|
2022
Q4 | $201K | Buy |
46,557
+9,832
| +27% | +$57K | ﹤0.01% | 5445 |
|
|
2022
Q3 | $276K | Sell |
36,725
-113,293
| -76% | -$981K | ﹤0.01% | 4833 |
|
|
2022
Q2 | $1.51M | Sell |
150,018
-25,549
| -15% | -$286K | ﹤0.01% | 3370 |
|
|
2022
Q1 | $2.17M | Buy |
175,567
+61,781
| +54% | +$955K | ﹤0.01% | 3353 |
|
|
2021
Q4 | $2.6M | Sell |
113,786
-123,943
| -52% | -$2.94M | ﹤0.01% | 3500 |
|
|
2021
Q3 | $5.26M | Sell |
237,729
-22,476
| -9% | -$357K | ﹤0.01% | 2621 |
|
|
2021
Q2 | $3.37M | Buy |
260,205
+5,373
| +2% | +$68.4K | ﹤0.01% | 3069 |
|
|
2021
Q1 | $3.31M | Buy |
254,832
+38,749
| +18% | +$562K | ﹤0.01% | 3024 |
|
|
2020
Q4 | $2.99M | Buy |
216,083
+46,767
| +28% | +$681K | ﹤0.01% | 2987 |
|
|
2020
Q3 | $2.49M | Buy |
169,316
+67,534
| +66% | +$978K | ﹤0.01% | 2851 |
|
|
2020
Q2 | $1.65M | Sell |
101,782
-20,620
| -17% | -$330K | ﹤0.01% | 3055 |
|
|
2020
Q1 | $1.78M | Buy |
122,402
+39,442
| +48% | +$696K | ﹤0.01% | 2863 |
|
|
2019
Q4 | $1.68M | Buy |
82,960
+75,906
| +1,076% | +$699K | ﹤0.01% | 3724 |
|
|
2019
Q3 | $38K | Buy |
7,054
+611
| +9% | +$3.7K | ﹤0.01% | 6342 |
|
|
2019
Q2 | $42K | Sell |
6,443
-581
| -8% | -$3.7K | ﹤0.01% | 6063 |
|
|
2019
Q1 | $46K | Sell |
7,024
-1,158
| -14% | -$7.68K | ﹤0.01% | 5606 |
|
|
2018
Q4 | $55K | Sell |
8,182
-120,788
| -94% | -$697K | ﹤0.01% | 5999 |
|
|
2018
Q3 | $857K | Buy |
128,970
+8,535
| +7% | +$47.9K | ﹤0.01% | 3985 |
|
|
2018
Q2 | $678K | Buy |
120,435
+5,000
| +4% | +$27.9K | ﹤0.01% | 4088 |
|
|
2018
Q1 | $599K | Sell |
115,435
-3,400
| -3% | -$18.2K | ﹤0.01% | 4088 |
|
|
2017
Q4 | $538K | Buy |
118,835
+26,000
| +28% | +$144K | ﹤0.01% | 4241 |
|
|
2017
Q3 | $582K | Sell |
92,835
-5,705
| -6% | -$36K | ﹤0.01% | 4102 |
|
|
2017
Q2 | $604K | Sell |
98,540
-13,774
| -12% | -$92.8K | ﹤0.01% | 3984 |
|
|
2017
Q1 | $824K | Buy |
112,314
+13,405
| +14% | +$61.9K | ﹤0.01% | 3689 |
|
|
2016
Q4 | $208K | Buy |
98,909
+29,549
| +43% | +$95.1K | ﹤0.01% | 4762 |
|
|
2016
Q3 | $209K | Buy |
+69,360
| New | +$187K | ﹤0.01% | 4520 |
|
|
2016
Q2 | – | Sell |
-2,019
| Closed | -$6K | – | 7709 |
|
|
2016
Q1 | $6K | Sell |
2,019
-14,891
| -88% | -$36K | ﹤0.01% | 6908 |
|
|
2015
Q4 | $42K | Buy |
+16,910
| New | +$45.9K | ﹤0.01% | 5966 |
|
Other funds holding AUPH
TCM
NMC
